The Global Needle Free Injection System Market is projected to reach US $20.17 billion, at a CAGR of 15.5% during the forecast period.
Growth in this Needle Free Injection System Market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of Needle Free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced Needle Free injection solutions in the market. These strategies help market players to strengthen their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the Global Needle Free Injection System Market.
The jet-based Needle Free injectors are expected to witness the highest growth during the forecast period
Needle Free Injection System Market segmentation:
· based on product.
· based on technology.
· based on type.
· based on site of delivery.
· based on applications
· based on end-user
· based on regions.
The high growth in this Needle Free Injection System Market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth.
The Major Players Operating in the Needle Free Injection System Market:
The needle free injection system market is a fragmented market, with several big and emerging players.Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
Geographical Detailed Analysis for Needle Free Injection System Market:
North America is expected to dominate the market, followed by Europe.
The Needle Free injection system market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further sub segmented into the U.S. and Canada; while Europe is further sub segmented into Germany, France, the U.K. Italy, Spain, and Rest of Europe (RoE); Asia is further sub segmented into Japan, China, India and Rest of Asia (RoA).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly